Cell saver not cost-effective in single-level lumbar surgery

October 15, 2012 in Surgery

Cell saver not cost-effective in single-level lumbar surgery

Use of intraoperative blood salvage (cell saver) is not cost-effective for adult patients undergoing single-level posterior lumbar decompression and fusion surgery, according to research published online Oct. 5 in Spine.

(HealthDay)—Use of intraoperative blood salvage (cell saver) is not cost-effective for adult patients undergoing single-level posterior lumbar decompression and fusion (PLDF) surgery, according to research published online Oct. 5 in Spine.

Chelsea E. Canan, M.P.H., from the Norton Leatherman Spine Center in Louisville, Ky., and colleagues retrospectively reviewed from 180 randomly selected who underwent a single-level PLDF. Costs were calculated for allogeneic , setting up the cell saver recovery system, and infusing autologous blood from cell saver. Effectiveness was measured by allogeneic blood transfusions averted and quality-adjusted life-years (QALYs).

The researchers found that the transfusion rate decreased from 40.0 to 38.7 percent with the cell saver approach, with an incremental cost-effectiveness ratio (ICER) of $55,538 per allogeneic transfusion averted. The cell saver approach was considered not cost-effective, with an ICER of $5,555,380 per QALY gained—well above the cost-effectiveness threshold of $100,000 per QALY gained.

"The use of cell saver during a single-level PLDF does not significantly reduce the need for allogeneic blood transfusion and is not cost-effective," Canan and colleagues conclude. "Further studies are needed to evaluate the necessity for cell saver among other types of ."

More information: Abstract
Full Text (subscription or payment may be required)

Journal reference: Spine search and more info website

Copyright © 2012 HealthDay. All rights reserved.

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Sexual function in older adults with thoracolumbar-pelvic instrumentation

Surgeons investigated sexual function in 62 patients, 50 years and older, who had received extensive spinal–pelvic instrumentation for spinal deformity at the University of Virginia Health Center. Based on their results, ...

Surgery created 6 hours ago | popularity not rated yet | comments 0

Challenges encountered in surgical management of spine trauma in morbidly obese patients

Physicians at Monash University and The Alfred Hospital in Melbourne, Australia describe the logistic, medical, and societal challenges faced in treating spine trauma in morbidly obese patients. Based on a case series of ...

Surgery created 6 hours ago | popularity not rated yet | comments 0

Study looks at risk factors for rupture or bleeding of arachnoid cysts in children

Arachnoid cysts are a common type of brain lesion that is usually harmless, but with a risk of rupture or bleeding. A new study identifies risk factors for rupture or bleeding in children with "incidentally" detected arachnoid ...

Surgery created 6 hours ago | popularity not rated yet | comments 0

Study supports 'aggressive' treatment for posterior fossa hematoma in newborns

Posterior fossa subdural hematoma (PFSDH) is a serious and rare condition in newborns, generally occurring after difficult deliveries. But with appropriate treatment, there's an excellent chance of good long-term outcomes ...

Surgery created May 20, 2013 | popularity not rated yet | comments 0

More than one-third of Texas women still receive unnecessary breast biopsy surgery

Many women in Texas who are found to have an abnormality on routine mammogram or discover a lump in one of their breasts end up having an old-fashioned surgical biopsy to find out whether the breast abnormality is malignant. ...

Surgery created May 17, 2013 | popularity not rated yet | comments 0


New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Researchers find genetic risk factor for pulmonary fibrosis

A paper recently published in the New England Journal of Medicine and co-written by physicians and scientists at the University of Colorado School of Medicine finds that an important genetic risk factor for pulmonary fibros ...

Biomarkers discovered for inflammatory bowel disease

Using the Department of Defense Serum Repository (DoDSR), University of Cincinnati (UC) researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and ...

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

Post-approval TAVI registry shows high rates of device success at one year

One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, ...

Biodegradable stent proves non-inferior to drug-eluting stent

The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...